New York City-based tech company Inductive Bio has secured up to $21m from the US Advanced Research Projects Agency for Health (ARPA-H) to lead the development of AI drug toxicity prediction models, ...

Managing complex medical conditions often requires the simultaneous use of multiple different drugs, referred to as polypharmacy. While necessary, this significantly increases the risk of drug-drug ...

Drug-drug interactions (DDI) can cause adverse drug reactions during the co-administration of multiple drugs, necessitating accurate and scalable prediction tools. While deep learning models have ...